198
Views
5
CrossRef citations to date
0
Altmetric
Research Articles

Nanostructured lipid carrier-mediated lung targeted drug delivery system to enhance the safety and bioavailability of clofazimine

ORCID Icon & ORCID Icon
Pages 385-393 | Received 20 Jul 2020, Accepted 01 Feb 2021, Published online: 01 Mar 2021

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Tanvirul Hye, Sakib M. Moinuddin, Tanoy Sarkar, Trieu Nguyen, Dipongkor Saha & Fakhrul Ahsan. (2023) An evolving perspective on novel modified release drug delivery systems for inhalational therapy. Expert Opinion on Drug Delivery 20:3, pages 335-348.
Read now

Articles from other publishers (4)

Arthur Cavalcante Hatae, Cesar Augusto Roque-Borda & Fernando Rogério Pavan. (2023) Strategies for lipid-based nanocomposites with potential activity against Mycobacterium tuberculosis: Microbial resistance challenge and drug delivery trends. OpenNano 13, pages 100171.
Crossref
Keita Yamanouchi, Tomoki Ishimaru, Takuya Kakuno, Yuki Takemoto, Sho Kawatsu, Keiji Kondo, Masato Maruyama & Kazutaka Higaki. (2023) Improvement and characterization of oral absorption behavior of clofazimine by SNEDDS: Quantitative evaluation of extensive lymphatic transport. European Journal of Pharmaceutics and Biopharmaceutics 187, pages 141-155.
Crossref
Shamama Javed, Bharti Mangla, Yosif Almoshari, Muhammad H. Sultan & Waquar Ahsan. (2022) Nanostructured lipid carrier system: A compendium of their formulation development approaches, optimization strategies by quality by design, and recent applications in drug delivery. Nanotechnology Reviews 11:1, pages 1744-1777.
Crossref
Amarjitsing Rajput, Satish Mandlik & Varsha Pokharkar. (2021) Nanocarrier-Based Approaches for the Efficient Delivery of Anti-Tubercular Drugs and Vaccines for Management of Tuberculosis. Frontiers in Pharmacology 12.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.